AMSNYSEMKTHealthcare

Public company intelligence preview

AMERICAN SHARED HOSPITAL SERVICES

2 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
2
0 filed in the last 30 days
Acquisition / disposition count
2/0
Buy / Sell
Unique insiders active in the last year
1
Current insider positions tracked
4
4 active, 0 exited

Insider compensation

Public aggregate: $406757.65 average total compensation across covered insiders.

Governance movement

Public aggregate: 2 governance events in the last year.

Institutional ownership

Public aggregate: 19 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
0
Restricted-sale insiders, 1Y
0
Planned sale shares, 1Y
0
Planned sale value, 1Y
$0.00
Insiders covered
7
Latest year: 2025
Personnel changes, 1Y
2
Board appointments, 1Y
2
Board departures, 1Y
1

Market context

Basic quote context for the preview.

Price
$1.35
Market cap
$8.9M
Volume
4,999
EPS
$-0.09
Revenue
$7.1M
Employees
84

Company note

Context before the data.

Company Overview

American Shared Hospital Services, in the Healthcare sector and Medical Care Facilities industry, provides turn-key stereotactic radiosurgery and advanced radiation therapy solutions through two main businesses: equipment leasing and direct patient services. Its leasing model centers on Gamma Knife and proton beam therapy systems placed at hospitals and cancer centers under fee-per-use or revenue-sharing arrangements, while its owned treatment centers operate in the U.S. and Latin America, including facilities in Peru, Ecuador, Rhode Island, Mexico, and development projects in Brazil? actually Rhode Island and Guadalajara. Recent filings show the company is increasingly shifting toward direct patient services, supported by the Rhode Island acquisition and the Puebla, Mexico center, while leasing revenue has been pressured by contract expirations and lower PBRT utilization. The business is capital-intensive, highly specialized, and dependent on reimbursement, procedure volumes, and access to advanced radiation technology.

Executive Compensation Practices

For a company like ASHS, executive compensation is likely tied more to revenue growth, cash flow, operating margin, utilization rates, and successful site expansion than to simple top-line growth alone, because the business has substantial capital costs and thin margins. In this Healthcare / Medical Care Facilities context, incentive plans often reflect metrics such as patient volume, equipment uptime, contract renewals, EBITDA or adjusted EBITDA, and successful integration of acquired facilities like the Rhode Island centers. The filings suggest compensation pressure would also come from liquidity management, debt covenant compliance, refinancing progress, and the ability to fund new Gamma Knife or LINAC installations without stressing the balance sheet. Because 2025 results included rising operating costs, negative working capital, and going-concern concerns, management incentives may be increasingly focused on preservation of cash and completion of financing arrangements rather than aggressive expansion alone.

Insider Trading Considerations

Insider trading patterns in ASHS should be viewed through the lens of a small, specialized healthcare operator with high dependence on reimbursement, contract renewals, and debt financing. Executives may have particularly strong private insight into near-term procedure trends, payer mix, equipment downtime, covenant negotiations, and the likelihood of refinancing the Fifth Third facility before its April 2026 maturity. Material developments such as the opening of new centers, the ramp-up of Puebla, the Esprit upgrade in Peru, or changes in CMS reimbursement proposals could all influence insider activity because they have direct impact on revenue visibility and liquidity. Given the company’s negative working capital, covenant defaults, and substantial doubt about continuation as a going concern, insider purchases or sales may be especially informative, but also more likely to be constrained by blackout periods and sensitivity to nonpublic financing discussions.

Unlock the full AMS insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.